Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Russia Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20042
20051
20067
20076
20086
200914
20105
20114
20123
20138
20145
20152
201612
20176
20185
20191
20203
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Terminated7
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S51
AstraZeneca13
Geropharm5
GlaxoSmithKline5
Eli Lilly and Company4
Takeda4
Allergan3
Janssen Research & Development, LLC3
Amgen1
Andromeda Biotech Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus97
Diabetes Mellitus, Type 267
Diabetes Mellitus, Type 119
Glucose Metabolism Disorders7
Metabolic Diseases6
Insulin Resistance5
Endocrine System Diseases4
Gastroparesis3
Cardiovascular Diseases2
Dyslipidemias2

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.